Patient
Generated Health Data Market is driven by consumer demand for proactive
healthcare management



The global patient generated health data market allows individuals to play an
active role in their own healthcare management and decision-making. Patient
generated health data refers to health-related data created, recorded, gathered
or inferred by or from patients or their designees to help address a health
concern. This includes data gathered from tools and medical records to help
track symptoms, treatment adherence, outcomes, or other indicators of health
that are outside of clinical health records. The ability to easily collect and
share personal health data can help identify potential problems early, monitor
existing conditions, and get medical advice remotely without visiting a
doctor's office. It also allows patients to take a more proactive role in their
own health, fitness and wellness.

The global patient generated health data market size was
valued at US$ 5.80 Bn in 2023 and is expected to reach US$ 19.06
Bn by 2030, growing at a Compound Annual Growth Rate (CAGR) of
18.5% from 2023 to 2030.



Key Takeaways

Key players operating in the global patient generated health data market
includes Ancestry, Gene By Gene, Ltd., 23andMe,Inc., Color Genomics,Inc, Myriad
Genetics,Inc, Mapmygenome, Positive Biosciences, Ltd, Futura Genetics, Helix
OpCo LLC, MyHeritage Ltd., Pathway Genomics, Veritas, Amgen, Inc., Xcode Life,
Diagnomics, Inc., Toolbox Genomics, SomaLogic, Inc., inui Health, AgeCurve,
QuickCheck Health, Biomeb, Metabolomic Discoveries GmbH, and Illumina, Inc.



The growing Global
Patient Generated Health Data Market Size wearables is driving the
market as they allow patients to easily track and share health data. Devices
like FitBits, Apple Watches and glucose monitors make it simple to monitor
vitals, activity levels and other metrics without visiting a doctor.

Get More
Insights on- Patient
Generated Health Data Market